Reflections on attribution and decisions in pharmacovigilance

Drug Safety

Volumn 33, Issue 10, 2010, Pages 805-809

  Caster, Ola ^a   Edwards, I Ralph ^a  

^a UPPSALA MONITORING CENTRE   (Sweden)

Author keywords

Adverse reaction monitoring; Pharmacovigilance

Indexed keywords

CLINICAL DECISION MAKING; DRUG INFORMATION; DRUG SURVEILLANCE PROGRAM; EDITORIAL; EVIDENCE BASED PRACTICE; HUMAN; INTERNAL CONSISTENCY; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; PHOCOMELIA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADVERSE DRUG REACTION REPORTING SYSTEMS; COMMUNICATION; DATA INTERPRETATION, STATISTICAL; DECISION MAKING; ECTROMELIA; HUMANS; PHARMACEUTICAL PREPARATIONS; THALIDOMIDE;

EID: 77956318203     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11532460-000000000-00000     Document Type: Editorial

References (9)

1. Galloway JL, Delgado I, Ros MA, et al. A reevaluation of X-irradiation-induced phocomelia and proximodistal limb patterning. Nature 2009; 460 (7253): 400-404
2. Aronson JK, Hauben M. Anecdotes that provide definitive evidence. BMJ 2006 Dec; 333 (7581): 1267-1269
3. Hill AB. The environment and disease: association or casuation? Proc R Soc Med 1965; 58 (5): 295-300
4. HaubenM, Aronson JK. Defining signal and its subtypes in pharmacovigilance based on a systematic review of previous definitions. Drug Saf 2009; 32 (2): 99-110
5. Edwards IR, Lindquist M. First, catch your signal! Drug Saf 2010; 33 (4): 257-260
6. Edwards IR, Lindquist M, Wiholm BE, et al. Quality criteria for early signals of possible adverse drug reactions. Lancet 1990 Jul; 336 (8708): 156-158
7. Kelly WN, Arellano FM, Barnes J, et al. Guidelines for submitting adverse event reports for publication. Drug Saf 2007; 30 (5): 367-373
8. Waller PC, Evans SJ. A model for the future conduct of pharmacovigilance. Pharmacoepidemiol Drug Saf 2003 Jan-Feb; 12 (1): 17-29
9. Bowdler J, editor. Effective communications in pharmacovigilance: the Erice report. Uppsala: The Uppsala Monitoring Centre, 1998